Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for GDRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -14.41M
March 31, 2026 -21.64M
December 31, 2025 -31.77M
September 30, 2025 -18.00M
June 30, 2025 -18.32M
March 31, 2025 -51.88M
December 31, 2024 -16.64M
September 30, 2024 -15.86M
June 30, 2024 -17.23M
March 31, 2024 -20.62M
December 31, 2023 -12.87M
September 30, 2023 -13.65M
Date Value
June 30, 2023 -14.96M
March 31, 2023 -14.29M
December 31, 2022 1.286M
September 30, 2022 -13.78M
June 30, 2022 -163.61M
March 31, 2022 -34.40M
December 31, 2021 -9.259M
September 30, 2021 -27.06M
June 30, 2021 -132.72M
March 31, 2021 -9.695M
December 31, 2020 -9.81M
September 30, 2020 -73.49M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. 0.00
SCWorx Corp. -0.0726M
Health Catalyst, Inc. 0.902M
Claritev Corp. -38.08M
iSpecimen, Inc. 0.00